Shuttle Pharmaceuticals Holdings, Inc. (SHPH) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
401 Professional Drive
Gaithersburg, MD 20879
United States of America (the)
Phone
240 403 4212
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2
First IPO Date
August 31, 2022
| Name | Title | Pay | Year Born |
| Christopher Robert Cooper | Interim Co-CEO & Director | 240,001 | 1970 |
| Ryan Trasolini | Co-Chief Executive Officer | 0 | N/A |
| Milton Brown | Co-Founder | 4,167 | 1965 |
| Yuying Liang | Chief Financial Officer | 177,511 | 1991 |
| Tyvin A. Rich | Chief Clinical Officer & Chief Medical Officer | 218,000 | 1948 |
| Michael Vander Hoek | Vice President for Operations and Regulatory | 506,634 | 1960 |
| Mira Jung | Co-Founder & Chief Scientific Officer for Biology | 0 | 1949 |
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.